Sleep Aids Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Sleep Aids Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)


The global sleep aids market is poised for steady growth, with its value projected to increase from $29.48 billion in 2024 to $40.15 billion by 2031, reflecting a CAGR of 4.50%. As the demand for effective sleep solutions escalates, the market is expected to grow substantially, catering to a wide array of consumers who are increasingly viewing sleep as a fundamental component of overall health and well-being.

Escalating Demand for Sleep Aids Propels Market Expansion

The global sleep aids market is experiencing a notable increase in demand, especially for products such as mattresses, pillows, chin straps, and nasal devices. These products have gained widespread popularity due to their accessibility and proven efficacy in enhancing sleep quality. As more individuals recognize the benefits of sound sleep, the adoption of these sleep aids is on the rise, significantly fueling market growth.

Consumers are now more inclined to prioritize their sleep health, reflected in their readiness to invest in products that promote better sleep. From high-end mattresses to cutting-edge sleep accessories, the market is meeting a diverse range of consumer demands, further driving its growth. The availability of these products on e-commerce platforms has also played a critical role in making them more accessible to a wider audience, thereby boosting the market's expansion.

Innovations in Sleep Monitoring and Engineering

The integration of digital technologies, particularly the Internet of Things (IoT), is transforming how sleep disorders are monitored and treated. Wearable devices and sleep engineering systems are becoming more advanced, offering consumers new ways to track and enhance their sleep quality. These technologies benefit not only those with sleep disorders but also the general population seeking to improve their sleep experiences.

Wearable sleep monitors, for example, have evolved to provide in-depth insights into sleep patterns, including sleep efficiency, stages of sleep, and potential sleep disorders. These devices utilize sophisticated sensors and algorithms to monitor sleep-related metrics, offering users a comprehensive understanding of their sleep health. Additionally, the rise of digital therapeutics (DTx) is noteworthy, as these innovations aim to address and potentially resolve sleep-related issues through non-invasive methods.

The growing interest in sleep as a vital aspect of overall well-being has driven the demand for digital sleep aids. As consumers become more knowledgeable about the importance of sleep, they increasingly turn to digital solutions that offer convenience and personalized insights. This trend is expected to continue driving market growth as more consumers seek out innovative sleep technologies.

Safety Concerns and Limitations of Digital Therapeutics Pose Challenges

Despite the promising growth of the sleep aids market, it faces several challenges. The use of pharmacological treatments for sleep disorders, for instance, is often associated with various adverse effects. Over-the-counter sleep aids, which frequently contain antihistamines, can lead to side effects such as dry mouth, dizziness, constipation, and blurred vision. Moreover, prolonged use of these medications can result in dependency and other health complications.

The limitations of digital therapeutics also present obstacles to market growth. While these technologies offer convenience and accessibility, they are often criticized for their lack of personalization and the high dropout rates associated with digital cognitive behavioral therapy (CBT). The absence of direct support from a therapist can make it challenging for users to remain engaged with the treatment, especially if they do not see immediate improvements in their sleep.

Additionally, some prescribed sleeping pills are linked to parasomnia, a disruptive sleep disorder that can cause individuals to engage in hazardous behaviors while still asleep. Patients taking certain medications, such as Z-drugs, may experience sleepwalking, sleep-eating, or even sleep-driving without being conscious of their actions. These safety concerns highlight the need for continued innovation in the development of safer and more effective sleep aids.

United States: A Leading Market for Sleep Aids

The United States remains a dominant player in the North American sleep aids market. The prevalence of sleep disorders in the U.S. is significantly high, driven by factors such as increased consumption of alcohol and tobacco, as well as rising levels of stress and anxiety. The presence of major industry players in the region, coupled with growing consumer awareness about the benefits of sleep aids, is contributing to the market's robust performance.

The U.S. market is also seeing increased adoption of devices like CPAP (Continuous Positive Airway Pressure) and BiPAP (Bilevel Positive Airway Pressure) machines, commonly used to treat sleep apnea and other chronic lung conditions. As the population ages and disposable incomes rise, the demand for these devices is expected to grow, further strengthening the market.

Germany: A Key Contributor to the European Market

Germany is emerging as a pivotal player in the European sleep aids market, driven by a growing awareness of sleep disorders and an aging population. Organizations like the British Sleep Society and the Survey Sleep Research Center are actively working to raise awareness about the risks associated with poor sleep, leading to increased demand for sleep aids in the region.

The aging population in Europe, particularly in Germany, is a significant factor driving market growth. As more people reach their senior years, the prevalence of sleep disorders such as insomnia and sleep apnea is expected to rise. This demographic trend is likely to fuel demand for sleep aids, especially those designed to address the unique needs of older adults.

China: An Emerging Market for Sleep Aids

China is quickly emerging as a key market for sleep aids, driven by lifestyle changes and a growing awareness of sleep health. The younger population in China is increasingly investing in high-quality sleep products, including luxury mattresses, bedding, and innovative sleep accessories. This trend reflects a broader shift towards prioritizing wellness and self-care.

As public awareness of sleep disorders grows, more people in China are turning to sleep aids to improve their sleep quality. The market is also benefiting from rising per capita income and a burgeoning middle class willing to spend on premium sleep products. This shift in consumer behavior is expected to significantly contribute to the growth of the sleep aids market in the Asia-Pacific region.

Competitive Analysis
•ResMed Inc.
•Koninklijke Philips N.V.
•Merck & Co. Inc.
•Drive DeVilbiss Healthcare LLC
•GlaxoSmithKline Plc.
•Fisher & Paykel Healthcare Limited
•Sanofi SA
•Pfizer Inc

Key Segments Covered in Global Industry Research

Product:
•Drugs

oInsomnia Treatment Drugs

Doxepin Hydrochloride

Eszopiclone

Ramelteon

Triazolam

Zaleplon

Quazepam

Others

oNarcolepsy Treatment Drugs

Modafinil

Sodium Oxybate

Armodafinil

Others
•Devices

oCPAP Devices

oBiPAP Devices

oAPAP Devices
•Others

oMattresses and Pillows

oChin Straps

oMouth Pieces and Nasal Devices

Indication:
•Insomnia
•Sleep Deprivation
•Narcolepsy
•Sleep Apnea
•Others

Distribution Channel:
•Hospital Pharmacies
•Retail Pharmacies
•e commerce
•Drug Stores
•Others

Region:
•North America
•Latin America
•Europe
•South Asia
•East Asia
•Oceania
•Middle East & Africa



Please note: Delivery Timelines - 5 working days.


1. Executive Summary
1.1. Global Sleep Aids Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Sleep Aids Market Outlook, 2019 - 2031
3.1. Global Sleep Aids Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
3.1.1. Key Highlights
3.1.1.1. Drugs
3.1.1.1.1. Insomnia Treatment Drugs
3.1.1.1.1.1. Doxepin Hydrochloride
3.1.1.1.1.2. Eszopiclone
3.1.1.1.1.3. Ramelteon
3.1.1.1.1.4. Triazolam
3.1.1.1.1.5. Zalepion
3.1.1.1.1.6. Quazepam
3.1.1.1.1.7. Others
3.1.1.1.2. Narcolepsy Treatment Drugs
3.1.1.1.2.1. Modafinil
3.1.1.1.2.2. Sodium Oxybate
3.1.1.1.2.3. Armodafinil
3.1.1.1.2.4. Others
3.1.1.2. Devices
3.1.1.2.1. CPAP Devices
3.1.1.2.2. BIPAP Devices
3.1.1.2.3. APAP Devices
3.1.1.3. Others
3.1.1.3.1. Mattresses and Pillows
3.1.1.3.2. Chin Straps
3.1.1.3.3. Mouth Pieces and Nasal Devices
3.2. Global Sleep Aids Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
3.2.1. Key Highlights
3.2.1.1. Insomnia
3.2.1.2. Sleep Deprivation
3.2.1.3. Narcolepsy
3.2.1.4. Sleep Apnea
3.2.1.5. Others
3.3. Global Sleep Aids Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
3.3.1. Key Highlights
3.3.1.1. Hospital Pharmacies
3.3.1.2. Retail Pharmacies
3.3.1.3. e commerce
3.3.1.4. Drug Stores
3.3.1.5. Others
3.4. Global Sleep Aids Market Outlook, by Region, Value (US$ Bn), 2019 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Sleep Aids Market Outlook, 2019 - 2031
4.1. North America Sleep Aids Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
4.1.1. Key Highlights
4.1.1.1. Drugs
4.1.1.1.1. Insomnia Treatment Drugs
4.1.1.1.1.1. Doxepin Hydrochloride
4.1.1.1.1.2. Eszopiclone
4.1.1.1.1.3. Ramelteon
4.1.1.1.1.4. Triazolam
4.1.1.1.1.5. Zalepion
4.1.1.1.1.6. Quazepam
4.1.1.1.1.7. Others
4.1.1.1.2. Narcolepsy Treatment Drugs
4.1.1.1.2.1. Modafinil
4.1.1.1.2.2. Sodium Oxybate
4.1.1.1.2.3. Armodafinil
4.1.1.1.2.4. Others
4.1.1.2. Devices
4.1.1.2.1. CPAP Devices
4.1.1.2.2. BIPAP Devices
4.1.1.2.3. APAP Devices
4.1.1.3. Others
4.1.1.3.1. Mattresses and Pillows
4.1.1.3.2. Chin Straps
4.1.1.3.3. Mouth Pieces and Nasal Devices
4.2. North America Sleep Aids Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
4.2.1. Key Highlights
4.2.1.1. Insomnia
4.2.1.2. Sleep Deprivation
4.2.1.3. Narcolepsy
4.2.1.4. Sleep Apnea
4.2.1.5. Others
4.3. North America Sleep Aids Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospital Pharmacies
4.3.1.2. Retail Pharmacies
4.3.1.3. e commerce
4.3.1.4. Drug Stores
4.3.1.5. Others
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Sleep Aids Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
4.4.1.2. U.S. Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
4.4.1.3. U.S. Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
4.4.1.4. Canada Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
4.4.1.5. Canada Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
4.4.1.6. Canada Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Sleep Aids Market Outlook, 2019 - 2031
5.1. Europe Sleep Aids Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
5.1.1. Key Highlights
5.1.1.1. Drugs
5.1.1.1.1. Insomnia Treatment Drugs
5.1.1.1.1.1. Doxepin Hydrochloride
5.1.1.1.1.2. Eszopiclone
5.1.1.1.1.3. Ramelteon
5.1.1.1.1.4. Triazolam
5.1.1.1.1.5. Zalepion
5.1.1.1.1.6. Quazepam
5.1.1.1.1.7. Others
5.1.1.1.2. Narcolepsy Treatment Drugs
5.1.1.1.2.1. Modafinil
5.1.1.1.2.2. Sodium Oxybate
5.1.1.1.2.3. Armodafinil
5.1.1.1.2.4. Others
5.1.1.2. Devices
5.1.1.2.1. CPAP Devices
5.1.1.2.2. BIPAP Devices
5.1.1.2.3. APAP Devices
5.1.1.3. Others
5.1.1.3.1. Mattresses and Pillows
5.1.1.3.2. Chin Straps
5.1.1.3.3. Mouth Pieces and Nasal Devices
5.2. Europe Sleep Aids Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
5.2.1. Key Highlights
5.2.1.1. Insomnia
5.2.1.2. Sleep Deprivation
5.2.1.3. Narcolepsy
5.2.1.4. Sleep Apnea
5.2.1.5. Others
5.3. Europe Sleep Aids Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospital Pharmacies
5.3.1.2. Retail Pharmacies
5.3.1.3. e commerce
5.3.1.4. Drug Stores
5.3.1.5. Others
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Sleep Aids Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
5.4.1.2. Germany Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.3. Germany Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.4. U.K. Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
5.4.1.5. U.K. Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.6. U.K. Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.7. France Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
5.4.1.8. France Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.9. France Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.10. Italy Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
5.4.1.11. Italy Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.12. Italy Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.13. Turkey Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
5.4.1.14. Turkey Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.15. Turkey Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.16. Russia Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
5.4.1.17. Russia Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.18. Russia Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.19. Rest of Europe Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
5.4.1.20. Rest of Europe Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.21. Rest of Europe Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Cassava Starch Market Outlook, 2019 - 2031
6.1. Asia Pacific Cassava Starch Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
6.1.1. Key Highlights
6.1.1.1. Drugs
6.1.1.1.1. Insomnia Treatment Drugs
6.1.1.1.1.1. Doxepin Hydrochloride
6.1.1.1.1.2. Eszopiclone
6.1.1.1.1.3. Ramelteon
6.1.1.1.1.4. Triazolam
6.1.1.1.1.5. Zalepion
6.1.1.1.1.6. Quazepam
6.1.1.1.1.7. Others
6.1.1.1.2. Narcolepsy Treatment Drugs
6.1.1.1.2.1. Modafinil
6.1.1.1.2.2. Sodium Oxybate
6.1.1.1.2.3. Armodafinil
6.1.1.1.2.4. Others
6.1.1.2. Devices
6.1.1.2.1. CPAP Devices
6.1.1.2.2. BIPAP Devices
6.1.1.2.3. APAP Devices
6.1.1.3. Others
6.1.1.3.1. Mattresses and Pillows
6.1.1.3.2. Chin Straps
6.1.1.3.3. Mouth Pieces and Nasal Devices
6.2. Asia Pacific Sleep Aids Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
6.2.1. Key Highlights
6.2.1.1. Insomnia
6.2.1.2. Sleep Deprivation
6.2.1.3. Narcolepsy
6.2.1.4. Sleep Apnea
6.2.1.5. Others
6.3. Asia Pacific Sleep Aids Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospital Pharmacies
6.3.1.2. Retail Pharmacies
6.3.1.3. e commerce
6.3.1.4. Drug Stores
6.3.1.5. Others
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Sleep Aids Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
6.4.1. Key Highlights
6.4.1.1. China Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
6.4.1.2. China Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.3. China Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.1.4. Japan Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
6.4.1.5. Japan Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.6. Japan Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.1.7. South Korea Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
6.4.1.8. South Korea Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.9. South Korea Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.1.10. India Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
6.4.1.11. India Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.12. India Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.1.13. Southeast Asia Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
6.4.1.14. Southeast Asia Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.15. Southeast Asia Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.1.16. Rest of Asia Pacific Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
6.4.1.17. Rest of Asia Pacific Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.18. Rest of Asia Pacific Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Sleep Aids Market Outlook, 2019 - 2031
7.1. Latin America Sleep Aids Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
7.1.1. Key Highlights
7.1.1.1. Drugs
7.1.1.1.1. Insomnia Treatment Drugs
7.1.1.1.1.1. Doxepin Hydrochloride
7.1.1.1.1.2. Eszopiclone
7.1.1.1.1.3. Ramelteon
7.1.1.1.1.4. Triazolam
7.1.1.1.1.5. Zalepion
7.1.1.1.1.6. Quazepam
7.1.1.1.1.7. Others
7.1.1.1.2. Narcolepsy Treatment Drugs
7.1.1.1.2.1. Modafinil
7.1.1.1.2.2. Sodium Oxybate
7.1.1.1.2.3. Armodafinil
7.1.1.1.2.4. Others
7.1.1.2. Devices
7.1.1.2.1. CPAP Devices
7.1.1.2.2. BIPAP Devices
7.1.1.2.3. APAP Devices
7.1.1.3. Others
7.1.1.3.1. Mattresses and Pillows
7.1.1.3.2. Chin Straps
7.1.1.3.3. Mouth Pieces and Nasal Devices
7.2. Latin America Sleep Aids Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
7.2.1.1. Insomnia
7.2.1.2. Sleep Deprivation
7.2.1.3. Narcolepsy
7.2.1.4. Sleep Apnea
7.2.1.5. Others
7.3. Latin America Sleep Aids Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospital Pharmacies
7.3.1.2. Retail Pharmacies
7.3.1.3. e commerce
7.3.1.4. Drug Stores
7.3.1.5. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Sleep Aids Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
7.4.1.2. Brazil Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
7.4.1.3. Brazil Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
7.4.1.4. Mexico Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
7.4.1.5. Mexico Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
7.4.1.6. Mexico Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
7.4.1.7. Argentina Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
7.4.1.8. Argentina Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
7.4.1.9. Argentina Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
7.4.1.10. Rest of Latin America Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
7.4.1.11. Rest of Latin America Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
7.4.1.12. Rest of Latin America Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Sleep Aids Market Outlook, 2019 - 2031
8.1. Middle East & Africa Sleep Aids Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
8.1.1. Key Highlights
8.1.1.1. Drugs
8.1.1.1.1. Insomnia Treatment Drugs
8.1.1.1.1.1. Doxepin Hydrochloride
8.1.1.1.1.2. Eszopiclone
8.1.1.1.1.3. Ramelteon
8.1.1.1.1.4. Triazolam
8.1.1.1.1.5. Zalepion
8.1.1.1.1.6. Quazepam
8.1.1.1.1.7. Others
8.1.1.1.2. Narcolepsy Treatment Drugs
8.1.1.1.2.1. Modafinil
8.1.1.1.2.2. Sodium Oxybate
8.1.1.1.2.3. Armodafinil
8.1.1.1.2.4. Others
8.1.1.2. Devices
8.1.1.2.1. CPAP Devices
8.1.1.2.2. BIPAP Devices
8.1.1.2.3. APAP Devices
8.1.1.3. Others
8.1.1.3.1. Mattresses and Pillows
8.1.1.3.2. Chin Straps
8.1.1.3.3. Mouth Pieces and Nasal Devices
8.2. Middle East & Africa Sleep Aids Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
8.2.1. Key Highlights
8.2.1.1. Insomnia
8.2.1.2. Sleep Deprivation
8.2.1.3. Narcolepsy
8.2.1.4. Sleep Apnea
8.2.1.5. Others
8.3. Middle East & Africa Sleep Aids Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.3.1.1. Hospital Pharmacies
8.3.1.2. Retail Pharmacies
8.3.1.3. e commerce
8.3.1.4. Drug Stores
8.3.1.5. Others
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Sleep Aids Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
8.4.1.2. GCC Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
8.4.1.3. GCC Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.4.1.4. South Africa Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
8.4.1.5. South Africa Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
8.4.1.6. South Africa Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.4.1.7. Egypt Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
8.4.1.8. Egypt Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
8.4.1.9. Egypt Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.4.1.10. Nigeria Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
8.4.1.11. Nigeria Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
8.4.1.12. Nigeria Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.4.1.13. Rest of Middle East & Africa Sleep Aids Market by Product, Value (US$ Bn), 2019 - 2031
8.4.1.14. Rest of Middle East & Africa Sleep Aids Market by Indication, Value (US$ Bn), 2019 - 2031
8.4.1.15. Rest of Middle East & Africa Sleep Aids Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Distribution Channel vs by Indication Heat map
9.2. Manufacturer vs by Indication Heatmap
9.3. Company Market Share Analysis, 2022
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. ResMed Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Koninklijke Philips N.V.
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Merck & Co. Inc.
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Drive DeVilbiss Healthcare LLC
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. GlaxoSmithKline Pic.
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Fisher & Paykel Healthcare Limited
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Sanofi SA
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Pfizer Inc
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings